In Vivo Differentiation of Magnetically Labeled Mesenchymal Stem Cells Into Hepatocytes for Cell Therapy to Repair Damaged Liver
Authors:
- Shenghong JuSJShenghong Ju
- Gao-Jun TengGTGao-Jun Teng
- Haihua LuHLHaihua Lu
- JiYang JinJJJiYang Jin
- Yu ZhangYZYu Zhang
- Aifeng ZhangAZAifeng Zhang
- Yicheng NiYNYicheng Ni
- 1 October 2010
- journal article
- Published by Wolters Kluwer Health in Investigative Radiology
- Vol. 45 (10) , 625-633
Abstract
It was unclear whether systemically administered mesenchymal stem cells (MSCs) labeled with magnetic nanoparticles can transdifferentiate into hepatocytes. In the present study, we built a new in vivo murine model for monitoring the transdifferentiation of magnetically labeled green fluorescent protein (GFP) positive MSCs into albumin-positive hepatocytes, under the carbon tetrachloride (CCl4) induced persistent liver damage. We also tracked magnetically labeled MSCs by using magnetic resonance imaging (MRI) in vivo. Among the liver damage groups, magnetically labeled GFP-positive MSCs (group A), GFP-positive MSCs (group B), and saline alone (group C) were intravenously injected. In control groups without CCl4 administration magnetically labeled GFP-positive MSCs (group D) were infused, whereas nothing was given in group E. MRI examinations were performed 24 hours and 4 weeks after cell injection in group A, B, and C. Liver-to-muscle contrast-to-noise ratios on T2*-weighted MR images were measured. At 4 weeks, 3 serum biologic liver function markers were analyzed, and mice in all groups were killed for histologic examination. The results showed that migration of transplanted magnetic labeled cells to the liver was successfully documented with in vivo MRI. Serum liver function markers were changed for all liver damage groups than nondamage control groups (P < 0.05), but still insignificant compared with group C (P > 0.05). Hematoxylin and eosin and Masson staining confirmed the presence of liver damage and hepatic fibrosis in group A, B, and C. Positive Prussian blue stained cells were highly correlated with GFP-positive cells in group A with an average matching rate of 95%. In group D, no iron-GFP-positive cells can be found in the liver. Albumin was expressed in (34% ± 6%) and (35% ± 7%) of GFP-positive cells in group A and B, respectively, and there was no significant difference between the 2 groups. Our data demonstrate that magnetic labeling technique synchronized well in GFP expressing MSCs and did not interfere with the transdifferentiation process and amending function of MSCs in vivo. Both magnetically labeled and unlabeled MSCs appeared to have the potential to differentiate into hepatocytes.Keywords
This publication has 51 references indexed in Scilit:
- Human mesenchymal stem cells xenografted directly to rat liver are differentiated into human hepatocytes without fusionBlood, 2005
- In vitro Hepatic Differentiation of Human Mesenchymal Stem CellsHepatology, 2004
- Expression of hepatocyte-like phenotypes in bone marrow stromal cells after HGF inductionBiochemical and Biophysical Research Communications, 2004
- A subpopulation of bone marrow cells depleted by a novel antibody, anti-Liv8, is useful for cell therapy to repair damaged liverBiochemical and Biophysical Research Communications, 2004
- Damaged epithelia regenerated by bone marrow–derived cells in the human gastrointestinal tractNature Medicine, 2002
- Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cellsJournal of Clinical Investigation, 2002
- Hepatocytes and Epithelial Cells of Donor Origin in Recipients of Peripheral-Blood Stem CellsNew England Journal of Medicine, 2002
- Liver cell transplantation: The road to clinical applicationJournal of Laboratory and Clinical Medicine, 2001
- Isolation, Characterization, and Transplantation of Bone Marrow-Derived Hepatocyte Stem CellsBiochemical and Biophysical Research Communications, 2001
- Muscle Regeneration by Bone Marrow-Derived Myogenic ProgenitorsScience, 1998